Texas 2019 - 86th Regular

Texas House Bill HB1849

Caption

Relating to the possession and administration of epinephrine auto-injectors in day-care centers; limiting liability.

Impact

The implications of HB 1849 significantly enhance the ability of day-care centers to respond to severe allergic reactions swiftly, ultimately aiming to save lives. By providing immunity from civil or criminal liability for individuals who administer epinephrine in good faith, this legislation encourages day-care staff to act decisively in emergencies without fear of legal repercussions. The bill's enactment necessitates that day-care centers adopt comprehensive training programs for their employees, ensuring staff are equipped to handle such high-stress medical situations effectively.

Summary

House Bill 1849 is focused on the possession and administration of epinephrine auto-injectors within day-care centers in Texas. The bill allows physicians to prescribe these auto-injectors in non-patient-specific terms, meaning day-care providers can maintain epinephrine on-site without needing a prescription linked to a specific child. Furthermore, the bill establishes guidelines for training employees in recognizing symptoms of anaphylaxis and administering the auto-injector correctly. It also mandates secure storage of these devices in locations that ensure ease of access for trained personnel in emergencies.

Sentiment

The overall sentiment around HB 1849 has been supportive, with advocates highlighting the importance of improving safety standards in child care facilities. It is perceived as a proactive measure that empowers day-care centers to manage potential allergic emergencies better. However, some concerns were raised regarding the implementation of training requirements and ensuring that all staff are adequately prepared to handle epinephrine administration competently.

Contention

Though there is broad support for the bill, discussions have surfaced around the adequacy of training provided to day-care employees. Critics point out that while the bill establishes basic training requirements, the quality and consistency of training across various centers could vary significantly. This inconsistency raises questions about whether all employees would be fully prepared in emergencies, potentially leading to hesitance in administering epinephrine during critical moments. Addressing these concerns is crucial to uphold the intent of the bill and ensure child safety.

Companion Bills

TX SB1735

Same As Relating to the possession and administration of epinephrine auto-injectors in day-care centers; limiting liability.

Previously Filed As

TX HB1418

Relating to disease prevention and preparedness information for emergency medical services personnel on certification or recertification.

Similar Bills

TX HB2283

Relating to the use of an epinephrine delivery device by certain entities.

TX SB1619

Relating to the use of an epinephrine delivery device by certain entities.

CA AB1651

Pupil health: emergency medical care: epinephrine auto-injectors.

UT HB0333

Medications in Schools Amendments

CA SB568

Pupil health: epinephrine delivery systems: public schools and programs.

TX HB3851

Relating to policies and training regarding the use of epinephrine auto-injectors by public institutions of higher education; providing immunity.

TX SB1367

Relating to policies and training regarding the use of epinephrine auto-injectors by public institutions of higher education; providing immunity.

NH HB63

Relative to the use of nasal spray to treat anaphylaxis.